Renal denervation device firm obtains $2.7M

08/16/2013 | (Boston)

Ablative Solutions has secured $2.7 million from 41 undisclosed backers, part of a funding round aiming for $5 million. The company, with offices in Michigan and California, is working on a perivascular renal denervation device that can be used to treat patients with high blood pressure by delivering radio-frequency energy straight to the nerves.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA